Kymera Therap Rg
Kymera Therapeutics, a clinical‑stage biotech from Watertown, MA, develops small‑molecule protein‑degraders targeting IRAK4, STAT6, and TYK2 for immuno‑inflammatory and autoimmune diseases. It partners with Sanofi to broaden development beyond oncology.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 225
- HQ: Watertown
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.